Discovery and Optimization of a Series of Vinyl Sulfoximine-Based Analogues as Potent Nrf2 Activators for the Treatment of Multiple Sclerosis.
Kim Y, Kim J, Kim B, Kim R, Kim HJ, Lee EH, Kim J, Park J, Jeong Y, Park SI, Kim H, Kang M, Lee J, Bahn YS, Choi JW, Park JH, Park KD.
Kim Y, et al. Among authors: bahn ys.
J Med Chem. 2024 Oct 10;67(19):17866-17892. doi: 10.1021/acs.jmedchem.4c01907. Epub 2024 Sep 26.
J Med Chem. 2024.
PMID: 39323296